-
Mashup Score: 2
Findings from the CheckMate-901 trial support the CHMP’s positive opinion of nivolumab plus chemotherapy in metastatic urothelial carcinoma.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Narayan Details How Nadofaragene Firadenovec Has Broken Ground as the First Gene Therapy for NMIBC - 5 day(s) ago
Vikram Narayan, MD, details the mechanism of action of the nadofaragene firadenovec and how the agent is impacting care for patients with BCG-unresponsive non–muscle invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Anktiva Approved for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Renal and Urology News - 5 day(s) ago
Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
A decision regarding EU marketing authorization is expected by June 2024.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2Narayan Details How Nadofaragene Firadenovec Has Broken Ground as the First Gene Therapy for NMIBC - 7 day(s) ago
Vikram Narayan, MD, details the mechanism of action of the nadofaragene firadenovec and how the agent is impacting care for patients with BCG-unresponsive non–muscle invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Nogapendekin alfa-inbakicept is now approved for the treatment of patients with BCG-unresponsive non-muscle invasive bladder carcinoma.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Narayan Details How Nadofaragene Firadenovec Has Broken Ground as the First Gene Therapy for NMIBC - 13 day(s) ago
Vikram Narayan, MD, details the mechanism of action of the nadofaragene firadenovec and how the agent is impacting care for patients with BCG-unresponsive non–muscle invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Novel Urine Biomarker Test May Reduce Unnecessary Cystoscopies in Patients With Bladder Cancer - 17 day(s) ago
A novel urine biomarker test may help reduce the number of cystoscopies necessary in high-risk patients with bladder cancer, according to findings presented at the European Association of Urology Cong…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Novel Urine Biomarker Test May Reduce Unnecessary Cystoscopies in Patients With Bladder Cancer - 18 day(s) ago
A novel urine biomarker test may help reduce the number of cystoscopies necessary in high-risk patients with bladder cancer, according to findings presented at the European Association of Urology Cong…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Dr. Mouw on next steps with ADC combinations in bladder cancer - 20 day(s) ago
“In the preclinical space, we continue to be interested in trying to understand the mechanistic underpinnings of these combination therapies,” says Kent W. Mouw, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
.@EMA_News has recommended frontline nivolumab plus gemcitabine/cisplatin for adults with metastatic or unresectable urothelial carcinoma for approval in the EU. #blcsm https://t.co/TmTS7aPPM0